A synthesis of the platelet aggregation inhibitor xemilofiban from L-aspartic acid. Confirmation of the absolute configuration.

被引：8

作者：

Boys, ML ^{[1
]}

机构：

[1] GD Searle & Co, Dept Chem Sci, Skokie, IL 60077 USA

来源：

TETRAHEDRON LETTERS | 1998年 / 39卷 / 21期

关键词：

D O I：

10.1016/S0040-4039(98)00602-9

中图分类号：

O62 [有机化学];

学科分类号：

070303 ; 081704 ;

摘要：

A synthesis of xemilofiban (SC-54684A) from L-aspartic acid has been achieved in an overall yield of 18 %, and the absolute configuration has been confirmed, (C) 1998 Elsevier Science Ltd. All rights reserved.

引用

页码：3449 / 3450

页数：2

共 7 条

[1] BABIAK K, 1996, Patent No. 5536869
[2] Corey E.J., 1972, TETRAHEDRON LETT, V13, P3769, DOI DOI 10.1016/S0040-4039(01)94157-7
[3] A very short, efficient and inexpensive synthesis of the prodrug form of SC-54701A - A platelet aggregation inhibitor
Cossy, J
Schmitt, A
Cinquin, C
Buisson, D
Belotti, D
[J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1997, 7 (13) : 1699 - 1700
[4] FORMATION OF AN OPTICALLY-ACTIVE ALPHA-AMINO ALDEHYDE IN THE BETA-LACTAM SERIES
LABIA, R
MORIN, C
[J]. CHEMISTRY LETTERS, 1984, (06) : 1007 - 1008
[5] OHKUBO M, Patent No. 9508536
[6] Salzmann T. N., 1980, J AM CHEM SOC, V102, p[6163, 49]
[7] POTENT IN-VITRO AND IN-VIVO INHIBITORS OF PLATELET-AGGREGATION BASED UPON THE ARG-GLY-ASP SEQUENCE OF FIBRINOGEN - (AMINOBENZAMIDINO)SUCCINYL (ABAS) SERIES OF ORALLY-ACTIVE FIBRINOGEN RECEPTOR ANTAGONISTS
ZABLOCKI, JA
RICO, JG
GARLAND, RB
ROGERS, TE
WILLIAMS, K
SCHRETZMAN, LA
RAO, SA
BOVY, PR
TJOENG, FS
LINDMARK, RJ
TOTH, MV
ZUPEC, ME
MCMACKINS, DE
ADAMS, SP
MIYANO, M
MARKOS, CS
MILTON, MN
PAULSON, S
HERIN, M
JACQMIN, P
NICHOLSON, NS
PANZERKNODLE, SG
HAAS, NF
PAGE, JD
SZALONY, JA
TAITE, BB
SALYERS, AK
KING, LW
CAMPION, JG
FEIGEN, LP
[J]. JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (13) : 2378 - 2394

← 1 →